Physician profile
Brett A Koder
NPI 1073508016
$1,247.70
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $75.35 · 2021: $347 · 2022: $204 · 2023: $49.62 · 2024: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $463.34 | 2019-2023 | Dupixent |
| Glaxosmithkline, LLC. | $266.86 | 2021-2024 | Nucala |
| Genzyme Corporation | $210.65 | 2021-2024 | |
| Acclarent, INC | $66.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.30 | 2019-2020 | |
| Kaleo, INC. | $47.05 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $38.74 | 2019 | |
| Olympus America INC. | $30.54 | 2020-2021 | |
| Intersect Ent, INC. | $29.82 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $22.39 | 2019 | |
| Aerin Medical INC. | $20.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Koder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.